Anteris Technologies Global (NASDAQ:AVR) Releases Earnings Results, Misses Expectations By $0.09 EPS

Anteris Technologies Global (NASDAQ:AVR) announced its quarterly earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.09), FiscalAI reports. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The company had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million.

Anteris Technologies Global Price Performance

NASDAQ AVR traded up $0.21 during trading hours on Tuesday, reaching $9.17. 1,102,251 shares of the company’s stock traded hands, compared to its average volume of 1,179,499. Anteris Technologies Global has a 52-week low of $3.17 and a 52-week high of $11.06. The firm has a market cap of $892.61 million, a PE ratio of -4.11 and a beta of 1.79. The firm has a 50-day simple moving average of $9.15 and a 200 day simple moving average of $7.31.

Wall Street Analysts Forecast Growth

AVR has been the topic of several research reports. Barclays lifted their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Finally, Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $16.00.

Insider Buying and Selling

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 174,721 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $8.10, for a total value of $1,415,240.10. Following the sale, the insider owned 5,439,000 shares in the company, valued at approximately $44,055,900. This represents a 3.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 2,373,000 shares of company stock worth $19,387,842 over the last 90 days. Insiders own 4.50% of the company’s stock.

Institutional Trading of Anteris Technologies Global

A number of hedge funds have recently made changes to their positions in AVR. Los Angeles Capital Management LLC bought a new position in Anteris Technologies Global during the 4th quarter valued at approximately $324,000. Wells Fargo & Company MN raised its stake in Anteris Technologies Global by 78.1% during the fourth quarter. Wells Fargo & Company MN now owns 37,157 shares of the company’s stock valued at $185,000 after buying an additional 16,291 shares during the last quarter. Bridgeway Capital Management LLC bought a new stake in Anteris Technologies Global in the fourth quarter worth $175,000. Macquarie Group Ltd. boosted its holdings in Anteris Technologies Global by 12,369.6% in the fourth quarter. Macquarie Group Ltd. now owns 33,668 shares of the company’s stock worth $168,000 after acquiring an additional 33,398 shares in the last quarter. Finally, Deutsche Bank AG grew its stake in shares of Anteris Technologies Global by 8.1% in the fourth quarter. Deutsche Bank AG now owns 28,865 shares of the company’s stock worth $144,000 after acquiring an additional 2,171 shares during the last quarter.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.